BLUEMTEC Co., Ltd. (439580.KQ) stock: key figures, P/E, revenue and dividend

Health Care · South Korea

Price
1,939.00 KRW
Market cap
65.63 bn KRW
P/E (2025)
–
P/S (2025)
0.35
Dividend yield
0.00 %
Net margin
-2.43 %
Return on equity (ROE)
-10.06 %
Return on assets (ROA)
-4.10 %

BLUEMTEC Co., Ltd. financials

Fiscal year20242025
Revenue133.29 bn KRW185.91 bn KRW
Gross profit13.30 bn KRW18.63 bn KRW
Operating income-6.90 bn KRW-1.97 bn KRW
EBIT-2.49 bn KRW-1.27 bn KRW
Net income-4.80 bn KRW-4.51 bn KRW
Diluted EPS – continuing operations-143.30 KRW-133.33 KRW

Full history since 2021, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About BLUEMTEC Co., Ltd.

BLUEMTEC Co., Ltd. operates a pharmaceutical distribution platform in South Korea and internationally. It is also involved in the healthcare digital marketing, IT development, fulfilment, pharmaceutical distribution data, and medical staff matching, and logistics businesses. The company was founded in 2015 and is headquartered in Yongin-si, South Korea.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.